Gene expression and cellular sources of inducible nitric oxide synthase during tumor promotion

Carcinogenesis

Volumn 17, Issue 9, 1996, Pages 2053-2059

  Robertson, Fredika M ^a   Long, Brooks W ^a   Tober, Kathleen L ^a   Ross, Mary S ^a   Oberyszyn, Tatiana M ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACETONE; DIMETHYLBENZ[A]ANTHRACENE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MOUSE; NEUTROPHIL; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; SKIN CARCINOGENESIS;

EID: 0029837739     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.9.2053     Document Type: Article

References (73)

1. Klein-Szanto, A.J.P., Conti, C.J., Aldaz, C.M., Clapp, N., Nesnow, S. and Slaga, T.J. (1986) Effects of chronic topical application of 12-O-tetradecanoylphorbol-13-acetate on the skin and internal organs of Sencar mice. Environ. Health Perspect., 68, 75-80.
2. Lewis, J.G. and Adams, D.O. (1987) Early inflammatory changes in the skin of Sencar mice and C57BL/6 mice following exposure to 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis, 8, 889-898.
3. Wei, L., Wei, H. and Frenkel, K. (1993) Sensitivity to tumor promotion of SENCAR and C57BL/6J mice correlates with oxidative events and DNA damage. Carcinogenesis, 14, 841-847.
4. Wei, H. and Frenkel, K. (1992) In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin. Cancer Res., 51, 4443-4449.
5. Floyd, R.A. (1990) The role of 8-hydroxyguanine in Carcinogenesis. Carcinogenesis, 11, 1447-1450.
6. Wood, M.L., Dizaroglu, M., Gajewski, E. and Essigmann, J.M. (1990) Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome. Biochemistry, 29, 7024-7032.
7. Cheng, K.C., Cahill, D.S., Kasai, H., Nishimura, S. and Loeb, L.A. (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J. Biol. Chem., 267, 166-172.
8. Kasai, H. and Nishimura, S. (1991) Formation of 8-hydroxyguanosine in DNA by oxygen radicals and its biological significance. In Sies, H. (ed.), Oxidative Stress: Oxidants and Antioxidants. Academic Press, London, UK, pp. 99-116.
9. Grollman, A.P. and Moriya, M. (1993) Mutagenesis by 8-oxo-guanine: an enemy within. Trends Genet., 9, 246-249.
10. Stuehr, D.J. and Marletta, M.A. (1985) Mammalian nitrite biosynthesis: mouse macrophages produce nitrite and nitrate in response to E. cols lipopolysaccharide. Proc. Natl Acad. Sci. USA, 82, 7738-7742.
11. Stuehr, D.J. and Marletta, M.A. (1987) Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-γ. J. Immunol., 139, 518-525.
12. Jun, C.D., Choi, B.M., Hoon-Ryu, Um, J.Y., Kwak, H.J., Lee, B.S., Paik, S.G., Kim, H.M. and Chung, H.T. (1994) Synergistic cooperation between phorbol ester and IFN-gamma for induction of nitric oxide synthesis in murine peritoneal macrophages. J. Immunol., 153, 3684-3690.
13. Curran, R.D., Billiar, T.R., Stuehr, D.J., Ochoa, J.B., Harbrecht, B.G., Flint, S.G. and Simmons, R.L. (1990) Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Annls Surg., 212, 462-469.
14. Crow, J.P. and Beckman, J.S. (1995) The role of peroxynitrite in nitric oxide-mediated toxicity. Curr. Topics Microbiol. Immunol., 196, 57-73.
15. Moncada, S. (1992) The L-arginine:nitric oxide pathway. Acta Physiol. Scand., 145, 201-227.
16. Moncada, S., Palmer, R.M.J. and Higgs, E.A. (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-142.
17. Forstermann, U. (1994) Biochemistry and molecular biology of nitric oxide synthases. Arzneimittel-Forschung, 44, 402-407.
18. Xie, Q.W., Cho, H.J., Calaycay, J., Mumford, R.A., Swiderek, K.M., Lee, T.D., Ding, A., Troso, T. and Nathan, C. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science, 256, 225-228.
19. Tepperman, B.L., Brown, J.F. and Whittle, B.J. (1993) Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am. J. Physiol., 265, G214-G218.
20. Felley-Boosc, E., Ambs, S., Lowenstein, C.J., Keefer, L.K. and Harris, C.C. (1994) Constitutive expression of inducible nitric oxide synthase in human bronchial epithelial cells induces c-fos and stimulates the cGMP pathway. Am. J. Resp. Cell Mol. Biol., 11, 159-164.
21. Adcock, I.M., Brown, C.R., Kwon, O. and Barnes, P.J. (1994) Oxidative stress induces NFKB DNA binding and inducible NOS mRNA in human epithelial cells. Biochem. Biophys. Res. Commun., 199, 1519-1524.
22. Asano, K., Chee, C.B., Gaston, B., Lilly, C.M., Gerard, C., Drazen, J.M. and Stamler, J.S. (1994) Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc. Natl Acad. Sci. USA, 91, 10089-10093.
23. Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J., 6, 3051-3064.
24. Hogg, N., Darley-Usmar, V.M., Graham, A. and Moncada, S. (1993) Peroxynitrite and atherosclerosis. Biochem. Soc. Trans., 21, 358-362.
25. Parrillo, J.E. (1993) Pathogenetic mechanisms of septic shock. New Engl. J. Med., 328, 1471-1477.
26. Gomez-Jimenez, J., Salgado, A., Mourelle, M., Martin, M.C., Segura, R.M., Peracaula, R. and Moncada, S. (1995) L-Arginine:Nitric oxide pathway in endotoxemia and human septic shock. Crit. Care Med., 23, 253-258.
27. Seekamp, A., Mulligan, M.S., Till, G.O. and Ward, P.A. (1993) Requirements for neutrophil products and L-arginine in ischemia-reperfusion injury. Am. J. Pathol., 142, 1217-1226.
28. Fehsel, K., Jalowy, A., Qi, S., Burkart, V., Hartmann, B. and Kolb, H. (1993) Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes, 42, 496-500.
29. Kaur, H. and Halliwell, B. (1994) Evidence for nitricoxide-mediatedoxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett., 350, 9-12.
30. Rachmilewitz, D., Stamler, J.S., Karmeli, F., Mullins, M.E., Singel, D.J., Loscalzo, J., Xavier, R.J. and Podolsky, D.K. (1993) Peroxynitrite-induced rat colitis - a new model of colonic inflammation. Gastroenterology, 105, 1681-1688.
31. Conner, J.R., Manning, P.T., Settle, S.L., Moore, W.M., Jerome, G.M., Webber, R.K., Tjoeng, F.S. and Currie, M.G. (1994) Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol., 273, 15-24.
32. G-methyl-L-arginine, an inhibitor of NOS. Biochem. Biophys. Res. Commun., 172, 1132-1138.
33. Pieper, G.M. and Peltier, B.A. (1995) Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J. Cardiovasc. Pharmacol., 25, 397-403.
34. 6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J. Med. Chem., 37, 3886-3889.
35. Wink, D.A. et al. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science, 254, 1001-1003.
36. Isomura, K., Chikahira, C., Teranishi, K. and Hamada, K. (1984) Induction of mutations and chromosome aberrations in lung cells following in vivo exposure of rats to nitrogen oxides. Mutat. Res., 136, 119-125.
37. Routledge, M.N., Wink, D.A., Keefer, L.K. and Dipple, A. (1993) Mutations induced by saturated aqueous nitric oxide in the pSP189 supF gene in human Ad293 and E.coli MBM7070 cells. Carcinogenesis, 14, 1251-1254.
38. Arroyo, P.L., Hatch-Pigtt, V., Mower, H.F. and Cooney, R.V. (1992) Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res., 281, 193-202.
39. Nguyen, T., Brunson, D., Crespi, C.L., Penman, B.W., Wishnok, J.S. and Tannenbaum, S.R. (1992) DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl Acad. Sci. USA, 89, 3030-3034.
40. Pryor, W.A., Jin, X. and Squadrito, G.L. (1994) One- and two-electron oxidations of methionine by peroxynitrite. Proc. Natl Acad. Sci. USA, 91, 11173-11177.
41. Salgo, M.G., Squadrito, G.L., Battista, J.R. and Pryor, W.A. (1995) Peroxynitrite causes DNA nicks in plasmid pBR322. Biochem. Biophys. Res. Commun., 210, 1025-1030.
42. Salgo, M.G., Bermudez, E., Squadrito, G.L. and Pryor, W.A. (1995) DNA damage and oxidation of thiols peroxynitrite causes in rat thymocytes. Arch. Biochem. Biophys., 322, 500-505.
43. Salgo, M.G., Squadrito, G.L., and Pryor, W.A. (1995) Peroxynitrite causes apoptosis in rat thymocytes. Biochem. Biophys. Res. Commun., 215, 1111-1118.
44. Lin, K.T., Xue, J.Y., Nomen, M., Spur, B. and Wong, P.Y. (1995) Peroxynitrite-induced apoptosis in HL-60 cells. J. Biol. Chem., 270, 16487-16490.
45. Inoue, S. and Kawanishi, S. (1995) Oxidative DNA damage induced by simultaneous generation of nitric oxide and Superoxide. FEBS Lett., 371, 86-88.
46. Yermilov, V., Rubio, J., Becchi, M., Freisen, M.D., Pignatelli, B. and Ohshima, H. (1995) Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis, 16, 2045-2050.
47. Oshima, H., Friesen, M., Brouet, I. and Bartsch, H. (1990) Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins. Chem. Toxicol., 28, 647-652.
48. van der Vliet, A., Eiserich, J.P., O'Neill, C.A., Halliwell, B., and Cross, C.E. (1995) Tyrosine modifications by reactive nitrogen species: a closer look. Arch. Biochem. Biophys., 319, 341-349.
49. Ischiropoulos, H. and al-Mehdi, A.B. (1995) Peroxynitrite-mediated oxidative protein modifications. FEBS Lett., 364, 279-282.
50. Shigenaga, M.K., Lee, H.H., Blount, B.C., Duncan, M.W., Glazer, A.N. and Ames, B.N. (1994) Assays for 3-nitrotyrosine, a biomarker of protein damage mediated by reactive byproducts of nitric oxide. J. Free Radical Biol. Med., 2, K3.
51. Haddad I.Y., Pataki, G., Hu, P., Galliani, C., Beckman, J.S. and Matalon, S. (1994) Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest., 94, 2407-2413.
52. Mordan, L.J., Burnett, T.S., Zhang, L.-X., Tom, J. and Cooney, R.V. (1993) Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T 1/2 fibroblasts. Carcinogenesis, 14, 1555-1559.
53. Reiners, J.J., Cantu, A., Thai, C. and Pavone, A. (1993) Differential co-promoting activities of alpha, beta, and gamma interferons in the murine skin two-stage carcinogenesis model. Carcinogenesis, 14, 367-372.
54. Robertson, F.M., Bijur, G.N., Oberyszyn, A.S., Nill, M.R., Boros, L.G., Spencer, W.J., Sabourin, C.L.K. and Oberyszyn, T.M. (1995) Interleukin-1α in murine multistage carcinogenesis. In Muhktar, H. (ed.), Skin Cancer: Mechanisms and Human Relevance. CRC Press, Boca Raton, FL pp. 251-272.
55. Nill, M.R., Oberyszyn, T.M., Ross, M.S., Oberyszyn, A.S. and Robertson, F.M. (1995) Temporal sequence of pulmonary cytokine gene expression in response to endotoxin in C3H/HeN endotoxin sensitive and C3H/HeJ endotoxin resistant mice. J. Leukemia Biol., 58, 1-13.
56. Wang, Q.S., Sabourin, C.L.K., Bijur, G.N., Robertson, F.M. and Stoner, G.D. (1996) Alterations in transforming growth factor-α and epidermal growth factor receptor expression during rat esophageal tumorigenesis. Mol. Carcinogen., 15, 144-153.
57. Nill, M.R., Oberyszyn, T.M., Ross, M.S., Oberyszyn, A.S., Ruberg., .L. and Robertson, F.M. (1995) Quantitation of inducible nitric oxide synthase gene expression during incisional wound healing. Surg. Forum, 47, 753-755.
58. Chharwal, V.J.S., Ngoi, S.S., Chan, S.T.F., Chia, Y.W. and Moochhala, S.M. (1994) Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa and surrounding peritumoral normal mucosa. Carcinogenesis, 15, 2081-2085.
59. Jenkins, D.C. et al. (1995) Roles of nitric oxide in tumor growth. Proc. Natl Acad. Sci. USA, 92, 4392-4396.
60. Thomsen, L.L., Miles, D.W., Happerfield, L., Bobrow, L.G., Knowles, R.G. and Moncada, S. (1995) Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72, 41-44.
61. Thomsen, L.L., Lawton, F.G., Knowles, R.G., Beesley, J.E., Riveros-Moreno, V. and Moncada, S. (1994) Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54, 1352-1354.
62. Stuehr, D.J. and Nathan, C.F. (1989) Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med., 169, 1543-1555.
63. Hibbs, J.B., Taintor, R.R., Vavrin, Z. and Rachlin, E.M. (1988) Nitric oxide: a cytotoxin activated macrophage effector molecule. Biochem. Biophys. Res. Commun., 157, 87-94.
64. Maragos, C.M., Wang, J.M., Hrabie, J.A., Oppenheim, J.J. and Keefer, L.K. (1993) Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res., 53, 564-568.
65. Hibbs, J.B., Taintor, R.R., Vavrin, Z., Granger, D.L., Drapier, J.-C., Amber, I.J. and Lancaster, J.R. (1990) Synthesis of nitric oxide from a terminal guanido nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. In Moncada, S. and Higgs, E.A. (eds), Nitric Oxide from L-Arginine: A Bioregulatory System. Elsevier, Amsterdam. The Netherlands, pp. 189-223.
66. Heck, D.E., Laskin, D.L., Gardner, C.R. and Laskin, J.D. (1992) Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J. Biol. Chem., 267, 21277-21280.
67. Juedes, M.J. and Wogan, G.N. (1996) Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat. Res. Fundam. Mol. Mech. Mutagen., 349, 51-61.
68. Robertson, F.M., Oberyszyn, T.M., Ge, S., Oberyszyn, A.S. and Williams, M.V. (1994) Mutational spectra induced by neutrophils from Sencar mice treated with tumor promoters. J. Free Radical Biol. Med., 2, N5.
69. Robertson, F.M., Beavis, A.J., Oberyszyn, T.M. ,O'Connell, S.M., Dokidis, A., Laskin, D.L., Laskin, J.D. and Reiners, J.J., Jr (1990) Production of hydrogen peroxide by murine epidermal keratinocytes following treatment with the tumor promoter 12-O-decanoyl-phorbol-myristate acetate. Cancer Res., 50, 6062-6067.
70. Fischer, S.M., Baldwin, J.K. and Adams, L.M. (1986) Effects of anti-promoters and strain of mouse on tumour promoter-induced oxidants in murine epidermal cells. Carcinogenesis, 7, 915-918.
71. Fischer, S.M. and Adams, L.M. (1985) Suppression of tumor promoter-induced chemiluminescence in mouse epidermal cells by several inhibitors of arachidonic acid metabolism. Cancer Res., 45, 3130-3136.
72. Taffe, B.G., Zweier, J.L., Pannell, L.K. and Kensler, T.W. (1989) Generation of reactive intermediates from the tumor promoter butylated hydroxytoluene hydroperoxide in isolated murine keratinocytes or by hematin. Carcinogenesis, 10, 1261-1268.
73. Taffe, B.G., Takahashi, N., Kensler, T.W. and Mason, R.P. (1987) Generation of free radicals from organic hydroperoxide tumor promoters in isolated mouse keratinocytes. Formation of alkyl andalkoxyl radicals from tert-butyl hydroperoxide and cumene hydroperoxide. J. Biol. Chem., 262, 12143-12149.